vimarsana.com

Latest Breaking News On - Traci mccarty - Page 4 : vimarsana.com

BioMarin to Host Third-Quarter 2023 Financial Results Conference Call and Webcast on Wednesday, November 1, at 4:30pm ET -October 17, 2023 at 08:31 am EDT

SAN RAFAEL, Calif., Oct. 17, 2023 /PRNewswire/ BioMarin Pharmaceutical Inc. today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a.

Jean jacques bienaimTraci mccartyMarni kottleInternational replay numberInternational numberBiomarin pharmaceutical incPrnewswire biomarin pharmaceutical incMarin pharmaceuticalChief executive officerCanada dial in numberDial in numberCanada replay dial in numberReplay dial in number

BioMarin to Present Data Showing Long-Term Benefit of VOXZOGO® (vosoritide) on Growth in Children with Achondroplasia at 2023 European Society for Paediatric Endocrinology (ESPE) Meeting

Label Expansion Decisions Expected from U.S. and European Regulatory Authorities in Q4 SAN RAFAEL, Calif., Sept. 21, 2023 /PRNewswire/ BioMarin Pharmaceutical Inc. , a global biotechnology.

United statesAndrew villaniTraci mccartyHank fuchsEarly access programWorldwide researchDrug administrationBiomarin pharmaceutical incEuropean society for paediatric endocrinologyPrnewswire biomarin pharmaceutical incEuropean commissionCommittee for medicinal products human useEuropean medicines agencyExchange commissionLabel expansion decisions expectedEuropean regulatory authorities

BioMarin Receives Positive CHMP Opinion in Europe to Expand Use of VOXZOGO® (vosoritide) to Treat Children Aged 4 Months and Older with Achondroplasia

European Commission Approval Decision Expected Q4 2023 Opinion Based on Positive Results from Global Phase 2 and Ongoing Extension Study U.S. Food and Drug Administration PDUFA Target Action Date.

Sachsen anhaltUnited statesTraci mccartyKlaus mohnikeAndrew villaniHank fuchsPrnewswire biomarin pharmaceutical incMagdeburg university hospitalEuropean commissionCommittee for medicinal products human useWorldwide researchEuropean medicines agencyBiomarin pharmaceutical incEu european union summary of product characteristicsDrug administrationExchange commission

BioMarin to Present Innovative Pipeline at R&D Day on September 12th in New York

Live Audio Webcast to Begin at 8:00 a.m. Eastern Time SAN RAFAEL, Calif., Sept. 11, 2023 /PRNewswire/ BioMarin Pharmaceutical Inc. , a global biotechnology company dedicated to transforming.

City ofUnited kingdomUnited statesSouth africaUniversity of minnesotaLos angelesHank fuchsJohnny mahlanguMelita irvingTraci mccartyAndrew villaniAmit nathwaniAndrew dauberBradley millerUniversity of the witwatersrandDepartment of pediatrics

BioMarin to Present Pipeline at Upcoming R&D Day on Tuesday, September 12th

BioMarin Leadership and External Medical Experts to Discuss 7 Product Candidates in Clinical Development as well as ROCTAVIAN and VOXZOGO New Indication Opportunities R&D Day to be Webcast.

United statesUniversity of minnesotaSouth africaCity ofUnited kingdomAmit nathwaniBradley millerAndrew villaniJohnny mahlanguAndrew dauberLos angelesTraci mccartyMelita irvingChildren national hospitalUniversity of the witwatersrandClinical coagulation laboratory

vimarsana © 2020. All Rights Reserved.